SRR607967
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- MITOTIC_SPINDLE+0.106
- HEME_METABOLISM+0.031
- DNA_REPAIR+0.015
- KRAS_SIGNALING_DN-0.001
- PI3K_AKT_MTOR_SIGNALING-0.036
- PEROXISOME-0.050
- SPERMATOGENESIS-0.093
- APICAL_JUNCTION-0.096
- WNT_BETA_CATENIN_SIGNALING-0.110
- GLYCOLYSIS-0.115
Top 10 suppressed
- TNFA_SIGNALING_VIA_NFKB-0.509
- INFLAMMATORY_RESPONSE-0.469
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.466
- TGF_BETA_SIGNALING-0.453
- APOPTOSIS-0.436
- ANGIOGENESIS-0.432
- ALLOGRAFT_REJECTION-0.427
- COAGULATION-0.425
- KRAS_SIGNALING_UP-0.418
- INTERFERON_ALPHA_RESPONSE-0.415
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR615249 | GTEX | — | 0.973 |
| 2 | SRR1467255 | GTEX | — | 0.973 |
| 3 | SRR1327811 | GTEX | — | 0.968 |
| 4 | SRR1364800 | GTEX | — | 0.968 |
| 5 | SRR1322291 | GTEX | — | 0.967 |
| 6 | SRR1324452 | GTEX | — | 0.966 |
| 7 | SRR1415215 | GTEX | — | 0.965 |
| 8 | SRR1459033 | GTEX | — | 0.965 |
| 9 | SRR1441224 | GTEX | — | 0.965 |
| 10 | SRR600957 | GTEX | — | 0.964 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 3 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| MITOTIC_SPINDLE | 0.106 | Inavolisib | — uncovered |
| HEME_METABOLISM | 0.031 | Temsirolimus | — uncovered |
| DNA_REPAIR | 0.015 | Idelalisib | — uncovered |